DNA Probes-Based Diagnostics - Global Strategic Business Report

  • ID: 338883
  • Report
  • Region: Global
  • 236 Pages
  • Global Industry Analysts, Inc
1 of 4

FEATURED COMPANIES

  • Abbott Molecular (USA)
  • bioMérieux (France)
  • Luminex Corporation (USA)
  • QIAGEN N.V. (Netherlands)
  • MORE
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.

This report analyzes the worldwide markets for DNA Probes-Based Diagnostics in US$ Million by the following Application Areas:
  • Infectious Diseases
  • Cancer Testing
  • Genetic Predisposition
  • Identity/Forensics
  • Others.
Company profiles are primarily based on public domain information including company URLs. The report profiles 46 companies including many key and niche players such as:
  • Abbott Molecular
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • bioMérieux
  • F. Hoffmann-La Roche Ltd.
  • GE Healthcare Life Sciences
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Molecular (USA)
  • bioMérieux (France)
  • Luminex Corporation (USA)
  • QIAGEN N.V. (Netherlands)
  • MORE

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study
Infectious Diseases
Cancer
Genetic Predisposition
Identity/Forensics
Other Diagnostic Applications

II. EXECUTIVE SUMMARY

1. MARKET DYNAMICS
What are DNA-Probes?
DNA-based Diagnostics
A Prelude
DNA Tests: Finding Use in Numerous Applications
DNA Probes: Robust Growth Ahead
Developed Markets: Traditional Revenue Contributors
The United States: Unraveling the Country’s Edge in DNA-based Diagnostics
Infectious Diseases Tests Dominate the DNA-based Diagnostics Market
Developing Countries Excel in Growth Prospects
Decoding the Genetic Puzzle
Advantages of DNA-Probe Tests
Growth Drivers in a Nutshell
Growth Inhibitors in a Nutshell
Genetic Profiling of Pathogens: A Road Less Traveled
Roche’s Entry into the Hall of Molecular Fame
DNA Technology: An Evolutionary Scan
Tracking Landmark Breakthroughs in DNA Diagnostics: 1953-2005
Market Opportunities

2. MARKET DRIVERS AND TRENDS
World’s Aging Population Drives the Popularity of DNA-Probe Tests
Global Aging Population Statistics
Opportunity Indicators
Table 1: Global Population of 65+ Individuals in ‘000s by Region for the Years 2015, 2020 & 2025 (includes corresponding Graph/Chart)
Table 2: Global Population Statistics for the 65+ Age Group in Select Countries (2017) (includes corresponding Graph/Chart)
Table 3: Life Expectancy at Birth (in Years) by Region for 2010-2015, 2020-2025 & 2045-2050 (includes corresponding Graph/Chart)
Rising Incidence of Chronic Diseases Fuels Demand for DNA Probes Based Diagnostics
Table 4: Worldwide Cancer Prevalence (2017): Percentage Prevalence of Diagnosed Cancer Conditions in Adult Population in Select Countries (includes corresponding Graph/Chart)
Table 5: Global Cancer Incidence (2015): Number of New Cancer Cases in Thousands by Type and Gender (includes corresponding Graph/Chart)
Table 6: Global Cancer Mortality (2015): Number of Cancer Related Deaths in Thousands by Type and Gender (includes corresponding Graph/Chart)
Table 7: Worldwide Diabetes Prevalence (2017 & 2045): Percentage Prevalence of Diabetes in Adult Population (20-79 Years) by Geographic Region (includes corresponding Graph/Chart)
Table 8: Leading Countries with Diabetes Population (20-79 Years) in Million for the Years 2017 and 2045 (includes corresponding Graph/Chart)
AIDS: A Global Epidemic
Facts & Figures
Table 9: HIV Infection Statistics Worldwide by Geographic Region: As of 2016 (includes corresponding Graph/Chart)
Table 10: HIV Infection Statistics Worldwide for Adults, Women and Children: As of 2016 (includes corresponding Graph/Chart)
Table 11: Worldwide AIDS Related Deaths by Geographic Region: 2016 (includes corresponding Graph/Chart)
Rise in Healthcare Spending in Developing Nations Bode Well for Market Growth
Table 12: Healthcare Spending as a Percentage of GDP in Select Countries (2016) (includes corresponding Graph/Chart)
Reimbursements: “Under the Umbrella”
Evolution of New & Virulent Infectious Agents
Challenges in Widespread Deployment of DNA-based Diagnostics
Improvements in Assay Capabilities
Information Handling & Processing: The Soft Side of Diagnostics
Integration: The Ultimate Challenge
DNA Probe Technology Gains Prominence in Diagnosing Vaginitis
Gene Banks
A Ray of Hope for the Future

3. DNA PROBES-BASED DIAGNOSTICS
A PRIMER
Diagnostic Gene Detection Products
Molecular Diagnostics: A Powerful Disease Detection Tool
DNA Probes-Based Products
Direct Detection of Target Sequence
Nucleic Acid Amplification
Gene Detection Using DNA Chips
Gene Detection by DNA Sequencing
The Dynamics of Key Enabling Technologies
Polymerase Chain Reaction (PCR)
In Situ Hybridization
Chemiluminescence
Gen-Probe Tigris
DNA Chips
Molecular Diagnostics
A Primer
Implications for Clinical Diagnostics
Need of the Hour
Impact of the Human Genome Project
“Tailored Patient Management”: An Epitomized Future of Molecular Diagnostics
Outlook

4. PRODUCT OVERVIEW
Background
Gene Probe Technology
What is DNA?
DNA Probes
Miniaturization: A Revolutionary Method in DNA Analysis
Gene Chip Technology
DNA Chips
Chromosome Painting Probes
Diagnostic Applications Based on DNA Probes: An Overview
Infectious Diseases
Respiratory Tract Infections
Diagnosis of Mycoplasma
DNA Probes to Detect Legionella Pneumophila
Detecting Tuberculosis through Rapid Diagnostic Tests
How the Technique Works
Limitations
Sexually Transmitted Diseases (STDs)
HIV
HTLV-1 Testing
Hepatitis Testing
Chlamydia DNA Probes
Detection of Intestinal Parasites
Entamoeba Histolytica
Salmonella
Malaria Testing
Identity/Forensics
DNA Profiling: A Key Forensic Tool
DNA-Based Forensic Diagnostics
Tracing Human Origins
Genetic Predisposition
Molecular HLA Testing
Human Leukocyte Antigen (HLA) Typing
Cancer Testing
Cancer: A Deadly Disease Afflicting Millions
Slow Detoxifiers: Potential Cancer Candidates
Improving Cancer Surgery through Diagnostic Tests
Types of Cancer
Chronic Lymphocytic Leukemia (CLL)
Breast Cancer
PCR Screening Technology for Breast Cancer
Eye Cancers
DNA Probes to Detect Retinoblastoma
Others
The Ames Test
Genetic Testing
Other Diagnostic Applications
Cystic Fibrosis
Duchenne’s Muscular Dystrophy
Huntington’s Disease
Diabetes
Detection of Multidrug Resistance
Bacterial Resistance to Antibiotics

5. RECENT INDUSTRY ACTIVITY
Thermo Fisher Scientific Acquires Affymetrix
Illumina Partners with Memorial Sloan Kettering
Cancer Genetics to Acquire BioServe Biotechnologies

6. FOCUS ON SELECT GLOBAL PLAYERS
Abbott Molecular (USA)
Beckman Coulter, Inc. (USA)
Becton, Dickinson and Company (USA)
bioMérieux (France)
F. Hoffmann-La Roche Ltd. (Switzerland)
GE Healthcare Life Sciences (UK)
Luminex Corporation (USA)
QIAGEN N.V. (Netherlands)
Siemens Healthineers (Germany)
Thermo Fisher Scientific, Inc. (USA)

7. GLOBAL MARKET PERSPECTIVE
Table 13: World Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 14: World Historic Review for DNA Probes-based Diagnostics by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 15: World 14-Year Perspective for DNA Probes-based Diagnostics by Geographic Region
Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart)
Table 16: World Recent Past, Current & Future Analysis for DNA Probes-based Infectious Disease Diagnostics by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 17: World Historic Review for DNA Probes-based Infectious Disease Diagnostics by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 18: World 14-Year Perspective for DNA Probes-based Infectious Disease Diagnostics by Geographic Region
Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart)
Table 19: World Recent Past, Current & Future Analysis for DNA Probes-based Cancer Diagnostics by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 20: World Historic Review for DNA Probes-based Cancer Diagnostics by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 21: World 14-Year Perspective for DNA Probes-based Cancer Diagnostics by Geographic Region
Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart)
Table 22: World Recent Past, Current & Future Analysis for DNA Probes-based Genetic Predisposition Diagnostics by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 23: World Historic Review for DNA Probes-based Genetic Predisposition Diagnostics by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 24: World 14-Year Perspective for DNA Probes-based Genetic Predisposition Diagnostics by Geographic Region
Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart)
Table 25: World Recent Past, Current & Future Analysis for DNA Probes-based Identity/Forensics Diagnostics by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 26: World Historic Review for DNA Probes-based Identity/Forensics Diagnostics by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 27: World 14-Year Perspective for DNA Probes-based Identity/Forensics Diagnostics by Geographic Region
Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart)
Table 28: World Recent Past, Current & Future Analysis for DNA Probes-based Other Diagnostics by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 29: World Historic Review for DNA Probes-based Other Diagnostics by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 30: World 14-Year Perspective for DNA Probes-based Other Diagnostics by Geographic Region
Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES
A.Market Analysis
United States: The Largest Market for DNA-Probes Diagnostics
Key Challenges Facing the Market
Rise of DNA-Based Home Testing Kits Market
Ageing Demographics: A Major Driving Factor
Table 31: US Elderly Population by Age Group for Years 1990, 2000, 2010 and 2015 (includes corresponding Graph/Chart)
Diabetes Pandemic in the US: An Opportunity for DNA Probes- based Diagnostics
Table 32: Diabetes Statistics in the US (2017 & 2045) (includes corresponding Graph/Chart)
Table 33: Diabetes Prevalence by Ethnicity (includes corresponding Graph/Chart)
Growing Cancer Incidence
An Opportunity Indicator for DNA Probes-Based Diagnostics
Table 34: New Cancer Cases in the US by Gender and Affected Site: 2017 (includes corresponding Graph/Chart)
Table 35: Incidence of Four Major Cancers by Gender & Age Group in the US (2017): New Cancer Cases for Male & Female for the Age Groups Under 45 Years; 45 Years and Above; Under 65 Years; 65 Years and Above (includes corresponding Graph/Chart)
Table 36: The US Breast Cancer Incidence in Women by State (2017): New Cases of Breast Cancer in Leading 15 States (includes corresponding Graph/Chart)
Strategic Corporate Developments
Focus on Select Key Players
B.Market Analytics
Table 37: The US Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics by Application Area
Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 38: The US Historic Review for DNA Probes-based Diagnostics by Application Area
Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 39: The US 14-Year Perspective for DNA Probes-based Diagnostics by Application Area
Percentage Breakdown of Revenues for Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart)

2. CANADA
A.Market Analysis
Cancer Incidence in Canada: Opportunity Indicator
Table 40: New Cancer Cases in Canada (2017): Breakdown of Cancer Incidence by Gender and Affected Site (includes corresponding Graph/Chart)
Table 41: New Cancer Cases in Canada by Province: 2017 (includes corresponding Graph/Chart)
Table 42: New Cancer Cases in Canada by Age Group: 2014 (includes corresponding Graph/Chart)
Table 43: Cancer Related Deaths in Canada (2017): Percentage Breakdown of Number of Deaths by Gender and Affected Site (includes corresponding Graph/Chart)
Diabetes Overview
Table 44: Diabetes Statistics in Canada (2017 & 2045) (includes corresponding Graph/Chart)
Table 45: Percentage Share Breakdown of Diabetic Population by Gender in Canada: 2016 (includes corresponding Graph/Chart)
Table 46: Percentage Share Breakdown of Diabetic Population by Age Group in Canada: 2016 (includes corresponding Graph/Chart)
B.Market Analytics
Table 47: Canadian Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics by Application Area
Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 48: Canadian Historic Review for DNA Probes-based Diagnostics by Application Area
Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 49: Canadian 14-Year Perspective for DNA Probes-based Diagnostics by Application Area
Percentage Breakdown of Revenues for Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart)

3. JAPAN
A.Market Analysis
Graying Population Spurs Growth
Table 50: Japanese Elderly (65+ Years) Population: 2000-2020 (includes corresponding Graph/Chart)
Diabetes Statistics
Table 51: Diabetes Statistics in Japan (2017 & 2045) (includes corresponding Graph/Chart)
B.Market Analytics
Table 52: Japanese Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics by Application Area
Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 53: Japanese Historic Review for DNA Probes-based Diagnostics by Application Area
Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 54: Japanese 14-Year Perspective for DNA Probes-based Diagnostics by Application Area
Percentage Breakdown of Revenues for Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart)

4. EUROPE
A.Market Analysis
Ageing Population Drives Demand
Table 55: European Country-wise Statistics of 65+ Population as % of Total Population: 2016 (includes corresponding Graph/Chart)
Cancer Incidence in Europe: An Opportunity Indicator for DNA Probes-Based Diagnostics
Table 56: Number of New Cancer Cases in Europe: 2012-2030 (includes corresponding Graph/Chart)
A Glance at Key Diabetes Statistics in Europe
Table 57: Diabetes and Population Statistics in Europe (2017 & 2045) (includes corresponding Graph/Chart)
Table 58: Diabetes Statistics in Europe (2017)
Number of Adults with Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in ‘000s) for Select Countries (includes corresponding Graph/Chart)
B.Market Analytics
Table 59: European Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics by Geographic Region
France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 60: European Historic Review for DNA Probes-based Diagnostics by Geographic Region
France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 61: European 14-Year Perspective for DNA Probes-based Diagnostics by Geographic Region
Percentage Breakdown of Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart)
Table 62: European Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics by Application Area
Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 63: European Historic Review for DNA Probes-based Diagnostics by Application Area
Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 64: European 14-Year Perspective for DNA Probes-based Diagnostics by Application Area
Percentage Breakdown of Revenues for Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart)

4a. FRANCE
A.Market Analysis
bioMérieux
A Major French Player
B.Market Analytics
Table 65: French Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics by Application Area
Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 66: French Historic Review for DNA Probes-based Diagnostics by Application Area
Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 67: French 14-Year Perspective for DNA Probes-based Diagnostics by Application Area
Percentage Breakdown of Revenues for Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart)

4b. GERMANY
A.Market Analysis
Siemens Healthineers
A Key German Player
B.Market Analytics
Table 68: German Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics by Application Area
Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 69: German Historic Review for DNA Probes-based Diagnostics by Application Area -Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 70: German 14-Year Perspective for DNA Probes-based Diagnostics by Application Area
Percentage Breakdown of Revenues for Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart)

4c. ITALY
Market Analysis
Table 71: Italian Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics by Application Area
Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 72: Italian Historic Review for DNA Probes-based Diagnostics by Application Area
Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 73: Italian 14-Year Perspective for DNA Probes-based Diagnostics by Application Area
Percentage Breakdown of Revenues for Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart)

4d. THE UNITED KINGDOM
A.Market Analysis
GE Healthcare Life Sciences
A Leading UK Player
B.Market Analytics
Table 74: The UK Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics by Application Area
Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 75: The UK Historic Review for DNA Probes-based Diagnostics by Application Area
Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 76: The UK 14-Year Perspective for DNA Probes-based Diagnostics by Application Area
Percentage Breakdown of Revenues for Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart)

4e. SPAIN
Market Analysis
Table 77: Spanish Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics by Application Area
Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 78: Spanish Historic Review for DNA Probes-based Diagnostics by Application Area -Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 79: Spanish 14-Year Perspective for DNA Probes-based Diagnostics by Application Area
Percentage Breakdown of Revenues for Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart)

4f. RUSSIA
Market Analysis
Table 80: Russian Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics by Application Area
Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 81: Russian Historic Review for DNA Probes-based Diagnostics by Application Area -Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 82: Russian 14-Year Perspective for DNA Probes-based Diagnostics by Application Area
Percentage Breakdown of Revenues for Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart)

4g. REST OF EUROPE
A.Market Analysis
Focus on Select Key Players
B.Market Analytics
Table 83: Rest of European Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics by Application Area
Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 84: Rest of European Historic Review for DNA Probes-based Diagnostics by Application Area
Infectious Diseases, Cancer, Genetic Predisposition, Identity/ Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 85: Rest of European 14-Year Perspective for DNA Probes-based Diagnostics by Application Area
Percentage Breakdown of Revenues for Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC
A.Market Analysis
Diabetes Statistics
An Overview
Table 86: Diabetes and Population Statistics in Western Pacific (2017 & 2045) (includes corresponding Graph/Chart)
Table 87: Diabetes Statistics in Western Pacific (2017)
Number of Adults with Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in ‘000s) for Select Countries (includes corresponding Graph/Chart)
Table 88: Diabetes and Population Statistics in South East Asia (2017 & 2045) (includes corresponding Graph/Chart)
Table 89: Diabetes Statistics in South East Asia (2017)
Number of Adults with Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in ‘000s) for Select Countries (includes corresponding Graph/Chart)
Strategic Corporate Development
B.Market Analytics
Table 90: Asia-Pacific Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics by Application Area
Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 91: Asia-Pacific Historic Review for DNA Probes-based Diagnostics by Application Area
Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 92: Asia-Pacific 14-Year Perspective for DNA Probes-based Diagnostics by Application Area
Percentage Breakdown of Revenues for Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart)

6. REST OF WORLD
A.Market Analysis
Diabetes in Latin America
A Glance at Key Statistics
Table 93: Diabetes and Population Statistics in Central and South America (2017 & 2045) (includes corresponding Graph/Chart)
Table 94: Diabetes Statistics in South & Central America (2017)
Number of Adults with Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in ‘000s) for Select Countries (includes corresponding Graph/Chart)
Diabetes in Middle East & North Africa, and Africa
Key Statistics
Table 95: Diabetes and Population Statistics in Middle East & North Africa (2017 & 2045) (includes corresponding Graph/Chart)
Table 96: Diabetes and Population Statistics in Africa (2017 & 2045) (includes corresponding Graph/Chart)
B.Market Analytics
Table 97: Rest of World Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics by Application Area
Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 98: Rest of World Historic Review for DNA Probes-based Diagnostics by Application Area
Infectious Diseases, Cancer, Genetic Predisposition, Identity/ Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 99: Rest of World 14-Year Perspective for DNA Probes-based Diagnostics by Application Area
Percentage Breakdown of Revenues for Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE
Total Companies Profiled: 46 (including Divisions/Subsidiaries 57)

  • The United States (37)
  • Canada (2)
  • Japan (1)
  • Europe (12)
    • France (1)
    • Germany (3)
    • The United Kingdom (2)
    • Italy (1)
    • Spain (1)
  • Rest of Europe (4)
  • Asia-Pacific (Excluding Japan) (5)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Abbott Molecular (USA)
  • Beckman Coulter, Inc. (USA)
  • Becton, Dickinson and Company (USA)
  • bioMérieux (France)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • GE Healthcare Life Sciences (UK)
  • Luminex Corporation (USA)
  • QIAGEN N.V. (Netherlands)
  • Siemens Healthineers (Germany)
  • Thermo Fisher Scientific, Inc. (USA)
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll